Ventipulmin Syrup

Ventipulmin® Syrup is a colorless, palatable syrup. Clenbuterol (4-amino-alpha-((tert-butylamino) methyl)-3,5-dichlorobenzyl alcohol hydrochloride), a beta-2-adrenergic agonist, provides bronchodilating properties with minimum effect on the cardiovascular system.

Only FDA-approved treatment to relieve reversible bronchospasm from respiratory conditions such as allergy induced respiratory distress, small airway disease or chronic obstructive pulmonary disease (COPD).

Remove safety cap and seal; replace with enclosed dispensing cap. Connect syringe (without needle) to dispensing tip and draw out appropriate volume of Ventipulmin¬ Syrup (clenbuterol hydrochloride). Administer to horse orally twice a day (b.i.d.). Initial dose is 0.5 mL/100 lbs body weight (0.8 mcg/kg) twice daily. See package insert for complete dosage schedule. Recommended duration of treatment at effective dose is 30 days. At end of 30-day treatment period, drug should be withdrawn to determine recurrence of signs. If signs return, repeat 30-day treatment regimen.

Store at controlled room temperature (15-30°C) 59-86°F. Avoid freezing. The safety cap should be placed on the bottle when not in use. Ventipulmin Syrup should not be used in pregnant mares near term or in horses suspected of having cardiovascular impairment.

Ventipulmin Syrup (clenbuterol hydrochloride) is indicated for management of horses affected with airway obstruction, such as chronic obstructive pulmonary disease (COPD).

Ventipulmin® Syrup is a colorless, palatable syrup. Clenbuterol (4-amino-alpha-((tert-butylamino) methyl)-3,5-dichlorobenzyl alcohol hydrochloride), a beta-2-adrenergic agonist, provides bronchodilating properties with minimum effect on the cardiovascular system.

Only FDA-approved treatment to relieve reversible bronchospasm from respiratory conditions such as allergy induced respiratory distress, small airway disease or chronic obstructive pulmonary disease (COPD).

Remove safety cap and seal; replace with enclosed dispensing cap. Connect syringe (without needle) to dispensing tip and draw out appropriate volume of Ventipulmin¬ Syrup (clenbuterol hydrochloride). Administer to horse orally twice a day (b.i.d.). Initial dose is 0.5 mL/100 lbs body weight (0.8 mcg/kg) twice daily. See package insert for complete dosage schedule. Recommended duration of treatment at effective dose is 30 days. At end of 30-day treatment period, drug should be withdrawn to determine recurrence of signs. If signs return, repeat 30-day treatment regimen.

Store at controlled room temperature (15-30°C) 59-86°F. Avoid freezing. The safety cap should be placed on the bottle when not in use. Ventipulmin Syrup should not be used in pregnant mares near term or in horses suspected of having cardiovascular impairment.

Ventipulmin Syrup (clenbuterol hydrochloride) is indicated for management of horses affected with airway obstruction, such as chronic obstructive pulmonary disease (COPD).